CN103931772A - Milk tea - Google Patents
Milk tea Download PDFInfo
- Publication number
- CN103931772A CN103931772A CN201410176781.XA CN201410176781A CN103931772A CN 103931772 A CN103931772 A CN 103931772A CN 201410176781 A CN201410176781 A CN 201410176781A CN 103931772 A CN103931772 A CN 103931772A
- Authority
- CN
- China
- Prior art keywords
- parts
- milk tea
- dry powder
- liquid extract
- lycopodium calvatum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses milk tea, and relates to health milk tea for preventing and curing hyperglycemia. The health milk tea for preventing and curing hyperglycemia provided by the invention comprises the following compositions in parts by weight: 15-30 parts of lycopodium clavatum liquid extract dry powder, 5-15 parts of tealeaf powder, 40-70 parts of skim milk powder and 5-15 parts of xylitol. The milk tea is sweet and fresh in flavor, so that new taste of the milk tea is added; through plumeria rubra, semen cuscutae, poria cocos, ophiopogon root and juncus, the balance of heart, liver, spleen, lung and kidney of the human body can be modulated; blood stasis is dispersed, the impurity and the symptom-complex of excessive eating are removed; by using lycopodium clavatum, the muscles are relaxed, the blood circulation is stimulated and the Qi is tonified and the collaterals are dredged, and therefore, the aim of reducing blood sugar level is achieved.
Description
Technical field
The present invention relates to a kind of health-care milk tea, especially a kind of health-care milk tea of preventing and treating hyperglycaemia.
Background technology
Prior art is not applied the health-care milk tea that lycopodium calvatum preparation prevents and treats hyperglycaemia, and the single and health care of taste has its limitation.Invention---the production method of balsom pear milky tea that the patent No. that Ru Chinese patent information centre announces is 200710025394, this Invention Announce a kind of production method of balsom pear milky tea, the batching of balsom pear milky tea is comprised of new fresh and tender balsam pear 10～45%, fresh tea leaf in its 2～lO%, fresh milk 5～15%, citric acid O.01～1%, xylitol O.1～5% and deionized water 45～75% by weight percentage; This invention is having its weak point aspect hypoglycemic health care such as grade.
Present young man's major part is all delithted with western fast food, does not like vegetables and fruit, and permanent poor eating habits may cause blood sugar higher.When empty stomach (sugar-free and any sugary food intake in 8 hours) blood sugar is higher than normal range (NR), be called hyperglycaemia, fasting blood-glucose normal value 4.0-6.1mmol/L, two hours blood glucoses are higher than normal range (NR) 7.8mmol/L after the meal, also can be called hyperglycaemia, blood sugar raises, and glucose in urine increases, can cause osmotic diuresis, thereby cause the symptom of diuresis; Blood sugar raises, large quantity of moisture is lost, and blood osmotic pressure also can correspondingly raise, and high blood oozes thirst center that can Hypothalamic Stimulation, thereby causes symptoms thirsty, many drinks; Due to the relative or absolute shortage of insulin, cause glucose in body not to be utilized, protein and fat consumption increase, thus cause weak, lose weight; For the sugar of recovering damage, maintain body activity, need many feeds; This has just formed typically " three-many-one-little " symptom.The order of severity of many drinks of diabetic, diuresis symptom and the state of an illness is proportional.In addition, patient eats manyly, and blood sugar is just higher, loses sugar also more in urine, and hunger is also just more severe, has finally caused vicious circle.
Summary of the invention
The object of the invention is to provide a kind of health-care milk tea of preventing and treating hyperglycaemia, to prevent people cause disease because blood sugar raises, for the treatment of the diabetes state of an illness, also play health care booster action.
Technical scheme: a kind of health-care milk tea of preventing and treating hyperglycaemia, formula forms and comprises lycopodium calvatum liquid extract dry powder 15-30 part, 5 parts of tea leaf powder 5-1, skimmed milk power 40-70 part, xylitol 5-15 part by weight; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: by lycopodium calvatum liquid extract dry powder, tea leaf powder, skimmed milk power, xylitol mixing and stirring in proportion, press 10-20g mono-bag packing after sterilizing.
As optimization, a kind of health-care milk tea of preventing and treating hyperglycaemia of the present invention, formula forms and comprises lycopodium calvatum liquid extract dry powder 15-30 part, 5 parts of tea leaf powder 5-1, skimmed milk power 40-70 part, xylitol 5-15 part by weight; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Lycopodium calvatum, toil temperature, expelling wind and clearing away cold, dehumidifying are subsided a swelling, are stimulated the circulation of the blood and cause the muscles and joints to relax.< < Hunan medicine will > > records lycopodium calvatum: sweet, flat.Nontoxic, enter the heart, kidney two warps, relax the muscles and stimulate the blood circulation, invigorating qi and dredging collateral.
Frangipanis, cool in nature, taste is sweet, light; Return large intestine, stomach warp, there is the effect of moistening lung removing toxic substances, clearing heat and expelling damp, laxation.
Radix Glycyrrhizae taste is sweet, flat.The thoughts of returning home, lung, spleen, stomach warp.Function cures mainly: invigorates the spleen and benefits qi, and clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, the anxious pain of four limbs contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Seed of Chinese dodder acrid-sweet flavor, property is flat, enters liver, kidney two warps.There is tonifying kidney and benefiting sperm, nourish the liver to improve visual acuity, antiabortive effect.
Poria cocos taste is sweet, light, property is flat, be used as medicine there is clearing damp and promoting diuresis, the function of beneficial spleen and stomach, antitoxic heart-soothing and sedative.Modern medicine study: Poria cocos energy enhanced machine body immunity function, pachymaran has significantly antitumor and protect the liver dirty effect.
The tuber of dwarf lilyturf, the micro-sugariness of property is bitter, cold, has nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, reinforcing yin essence benefit essence, five viscera settling effect.
Rush, is slightly cold; Sweet, light; The thoughts of returning home; Lung; Small intestine; Urinary bladder channel.Effect: promoting diuresis for stranguria; Clearing heart fire.Dark plum is sour, puckery, flat, returns liver, spleen, lung, large intestine channel.[function cures mainly] astringes the lung, and puckery intestines, promote the production of body fluid, claming ascaris.For chronic cough of deficiency lung, protracted dysentery laxation, abnormal heat is quenched one's thirst, ascariasis of biliary tract vomiting stomachache, ascariasis of biliary tract (< < Chinese pharmacopoeia > >).
The traditional Chinese medical science is thought diabetes, is mainly that the five internal organs are weak due to the plain body deficiency of Yin, multiple because of eating and drinking without temperance, overfeeding delicious food, and disorder of emotion, labor is wanted excessively, and causes deficiency of kidney-YIN, and lung stomach is scorching; Interpretation of the cause, onset and process of an illness emphasis is that the deficiency of Yin is scorching, and take the deficiency of Yin as this, and scorching is mark; With the passing of time disease prolongs, yin deficiency affecting yang, deficiency in both YIN and YANG; The deficiency of Yin is scorching, and the bright liquid in consumption Tianjin makes blood viscous, the not smooth stasis of blood that forms of blood; Yin deficiency affecting yang, the deficiency of yang is cold solidifying, also can cause sun in hemostasis.
Advantage of the present invention: 1, lycopodium calvatum Xin Wenyi impairment of yin blood of the present invention, therefore adapted frangipanis, Radix Glycyrrhizae are in harmonious proportion, make its institute partially, its taste is glycol, fresh and sweet, has channels sootheing and network vessel quickening, function of promoting blood circulation to disperse blood clots.
2, taste glycol of the present invention is pure and fresh, has increased the novel taste of milk tea.Seed of Chinese dodder tonifying kidney and benefiting sperm, Poria cocos clearing damp and promoting diuresis, beneficial spleen and stomach, the tuber of dwarf lilyturf is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, and rush clearing heart fire, dark plum are quenched one's thirst and are brought down a fever, and more contribute to promoting blood circulation and removing blood stasis hypoglycemic.
3, the present invention is by the balance of frangipanis, the seed of Chinese dodder, Poria cocos, the tuber of dwarf lilyturf, rush conditioning human body-centered liver spleen lung kidney the five internal organs, and stagnation resolvation is pure and impure quenches one's thirst, and relax the muscles and stimulate the blood circulation again, thereby invigorating qi and dredging collateral reaches hypoglycemic object with lycopodium calvatum.
4, Chinese medicine powder of the present invention has significant hypoglycemic activity to adrenaline hyperglycaemia mouse and alloxan hyperglycemia mouse.Each 20 of male and female mices are selected in experiment; Adopt respectively adrenaline and alloxan to set up hyperglycaemia mouse model, then give Chinese medicine powder of the present invention, glibenclamide, insoral is treated and survey blood sugar level.In the hyperglycemia mouse of bringing out at adrenaline, Chinese medicine powder of the present invention can make fasting serum glucose [(16. 58 ± 3. 92) mmol/L] be reduced to (7. 56 ± 2. 63) mmol/L, effect and glibenclamide comparison, no significant difference (P>0.05); In the hyperglycemia mouse of model induced by alloxan, the present invention is reduced to fasting serum glucose [(15. 56 ± 1. 83) mmol/L] (7. 55 ± 1.65) mmol/L, blood sugar reducing function is significantly better than insoral (P<0 05), and causes hypoglycemic side effect without glibenclamide.Conclusion: the present invention can significantly reduce the blood sugar level (P <0. 001) of 2 kinds of modeling animals, and makes blood sugar be down to normal level.
5, Chinese medicine powder of the present invention shows through more than the 60 routine sugared dung patients' that make a definite diagnosis clinical observation on the therapeutic effect, and the present invention has remarkable reduction glycosuria patient's blood sugar level, makes blood sugar recovery normal.
Clinical observation result of the present invention:
1.1 physical data: select the People's Hospital, city outpatient service diabetes B patient 60 examples, be divided at random two groups.Treatment group 30 examples, male 16 examples, female's 14 examples, 30～70 years old age, average (50 ± 1.5) year, the course of disease 6 months～15 years, average (8.0 ± 1.2) year; Control group 30 examples, male 18 examples, female's 12 examples, 29～70 years old age.Two groups of physical data comparing difference not statistically significants (P>0.05), have comparativity.
1.2 case selections: with reference to the World Health Organization's (WHO) diabetes diagnosis in 1999 and somatotype standard [1]: diabetic symptom+random time plasma glucose levels >=11.1mmol/L(200mg/dl).The patient's random packet that meets above-mentioned standard is carried out to observational study, and the patient that part takes traditional Chinese medicine stops former Chinese medicine and includes observation in after 2 weeks, and the patient's to be directly brought into not taking traditional Chinese medicine is observed.Two groups of patients all give diabetes Primary Care, comprise diet control, kinesiatrics and orally-taken blood sugar reducing Western medicine, and hypoglycemic Western medicine adopts melbine, according to blood sugar situation, carries out drug usage and dose adjustment.
1.3 methods of treatments: treatment group is taken Chinese medicine powder of the present invention taking on the basis of melbine.Basic side is comprised of the composition of raw materials of following weight portion: lycopodium calvatum 10, frangipanis 10, Radix Glycyrrhizae 3, the seed of Chinese dodder 5, Poria cocos 10, the tuber of dwarf lilyturf 5; Every natural gift are taken for three times, each 4 grams.Control group routine is taken melbine.Two groups are consistent in diet control, kinesiatrics, and be 2 months two groups of courses for the treatment of.
1.4 observation index: measure respectively fasting blood-glucose (FPG), postprandial blood sugar (2hBG), glycosylated hemoglobin (HbA1c), FPI (FINS), blood fat (TC, TG, HDL-C, LDL-C) before and after treatment, blood sugar determination of glucose oxidase, insulin is measured with putting the method for exempting from, blood fat is measured with automatic clinical chemistry analyzer, HOMA-IR employing Haffner etc. [3,4] in Homa model, calculate the formula of IR, be HOMA-IR=FPG * FINS/22.5 (FPG unit is mmol/L, and FINS unit is mU/L).
1.5 statistical methods: adopt SPSS 14.0 statistical analysis softwares to carry out statistical procedures.Measurement data adopts t check, enumeration data chi-square criterion.
2 results: before and after two groups of treatments, the variation of FPG, 2hBG, HbAIc, FINS and HOMA-IR refers to table 1.By in table 1, we can see, treat front two groups of patient FPG, 2hBG, HbAlc, FINS, the horizontal comparing difference not statistically significant of HOMA-IR (P>0.05); After treating, two groups of FPG, 2hBG, HbAlc, FINS, HOMA-IR levels have statistical significance (P<0.05 or P<0.01) with the front comparing differences for the treatment of, before treatment group patient's These parameters and treatment, relatively have significant difference (P<0.01).Prompting treatment group and control group all can reduce diabetes blood sugar, but it is more obvious with treatment group, to improve blood sugar.
The variation of FPG, 2hBG, HbAlc, FINS and HOMA-IR before and after table 1 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; The rear two groups of FINS for the treatment of and HOMA-IR compare ^P<0.05, ^^P<0.01.
Before and after two groups of patient treatments, the variation of TC, TG, HDL-C, LDL-C is in Table 2.From table 2, we can see the front two groups of patients' for the treatment of the horizontal comparing difference not statistically significant of TC, TG, HDL-C, LDL-C (P>0.05); After treatment, TC, TG, HDL-C, the LDL-C level of two groups have significant change, wherein TC, TG, LDL-C level have statistical significance (P<0.05) with the front comparing difference for the treatment of, and relatively have significant difference (P<0.01) before treatment group HDL-C level and treatment.Illustrate that treatment group and control group all can improve diabetic's blood lipid level, and more remarkable with treatment group effect.
The variation of TC, TG, HDL-C, the horizontal content of LDL-C before and after table 2 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; After treatment, two groups of indices are compared ^P<0.05, ^^P<0.01.
The specific embodiment
Embodiment 1: a kind of health-care milk tea of preventing and treating hyperglycaemia, and formula forms and comprises lycopodium calvatum liquid extract dry powder 15-30 part, 5 parts of tea leaf powder 5-1, skimmed milk power 40-70 part, xylitol 5-15 part by weight; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: by lycopodium calvatum liquid extract dry powder, tea leaf powder, skimmed milk power, xylitol mixing and stirring in proportion, press 10-20g mono-bag packing after sterilizing.
Embodiment 2: a kind of health-care milk tea of preventing and treating hyperglycaemia, and formula forms and comprises lycopodium calvatum liquid extract dry powder 15-30 part, 5 parts of tea leaf powder 5-1, skimmed milk power 40-70 part, xylitol 5-15 part by weight; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Preparation method is with embodiment 1.
Claims (2)
1. prevent and treat a health-care milk tea for hyperglycaemia, formula forms and comprises lycopodium calvatum liquid extract dry powder 15-30 part, 5 parts of tea leaf powder 5-1, skimmed milk power 40-70 part, xylitol 5-15 part by weight; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
2. prevent and treat a health-care milk tea for hyperglycaemia, formula forms and comprises lycopodium calvatum liquid extract dry powder 15-30 part, 5 parts of tea leaf powder 5-1, skimmed milk power 40-70 part, xylitol 5-15 part by weight; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410176781.XA CN103931772A (en) | 2014-04-29 | 2014-04-29 | Milk tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410176781.XA CN103931772A (en) | 2014-04-29 | 2014-04-29 | Milk tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103931772A true CN103931772A (en) | 2014-07-23 |
Family
ID=51179855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410176781.XA Pending CN103931772A (en) | 2014-04-29 | 2014-04-29 | Milk tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103931772A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105851333A (en) * | 2016-05-11 | 2016-08-17 | 长春中医药大学 | Preparation method of instant ginseng coffee milk tea |
| CN106472678A (en) * | 2015-08-26 | 2017-03-08 | 安徽恋尚你食品有限公司 | A kind of possess the health preserving milk tea improving inappetence effect |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102919373A (en) * | 2012-11-29 | 2013-02-13 | 仲珉 | Health milk tea granule |
| CN102934691A (en) * | 2012-11-29 | 2013-02-20 | 奉红英 | Healthcare camel milk |
-
2014
- 2014-04-29 CN CN201410176781.XA patent/CN103931772A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102919373A (en) * | 2012-11-29 | 2013-02-13 | 仲珉 | Health milk tea granule |
| CN102934691A (en) * | 2012-11-29 | 2013-02-20 | 奉红英 | Healthcare camel milk |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106472678A (en) * | 2015-08-26 | 2017-03-08 | 安徽恋尚你食品有限公司 | A kind of possess the health preserving milk tea improving inappetence effect |
| CN105851333A (en) * | 2016-05-11 | 2016-08-17 | 长春中医药大学 | Preparation method of instant ginseng coffee milk tea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103947925A (en) | Buckwheat porridge | |
| CN103931772A (en) | Milk tea | |
| CN103907957A (en) | Bamboo rat sausage | |
| CN103919176A (en) | Lobster meat sausage | |
| CN110074415A (en) | A kind of health food and preparation method thereof of internal organs expelling toxin opsonic | |
| CN103947916A (en) | Jelly | |
| CN103919153A (en) | Healthcare quail sausage | |
| CN103919022A (en) | Health-care steamed buns for preventing and treating hyperglycemia | |
| CN103907970A (en) | Whitebait meat balls | |
| CN103932226A (en) | Venison sausage | |
| CN103919175A (en) | Prawn sausage | |
| CN103919162A (en) | Mutton sausage | |
| CN103907963A (en) | Crocodile meat sausage | |
| CN103932072A (en) | Oatmeal | |
| CN103907956A (en) | Health horsemeat sausage | |
| CN103919155A (en) | Healthcare pigeon sausage | |
| CN103907952A (en) | Health-care ostrich meat sausage | |
| CN103918740A (en) | Premixed powder for preventing and treating hyperglycemia | |
| CN103907969A (en) | Reeves shad meat ball | |
| CN103932030A (en) | Maize gruel | |
| CN103907661A (en) | Health care biscuit capable of preventing hyperglycemia | |
| CN103911267A (en) | White spirit | |
| CN103911266A (en) | Yellow wine | |
| CN103919163A (en) | Ass meat sausage | |
| CN103919161A (en) | Healthcare pork sausage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140723 |
|
| WD01 | Invention patent application deemed withdrawn after publication |